View Older Stories View More Recent Stories
-
Berkshire Hills Reports Higher Third Quarter Net Income of $37.5 million, or $0.88 Per Share
-
Nasdaq's third-quarter profit rises on fintech strength
-
UPS Releases 3Q 2024 Earnings
-
Dow reports third quarter 2024 results
-
Renault beats Q3 forecasts as new launches lift sales
-
Northfield Bancorp, Inc. Announces Third Quarter 2024 Results
-
Align Technology misses third-quarter revenue estimates on weaker demand for teeth aligners
-
Whirlpool Announces Third-Quarter Results
-
ROLLINS, INC. REPORTS THIRD QUARTER 2024 FINANCIAL RESULTS
-
T-Mobile Delivers Industry-Leading Growth in Customers, Service Revenues, Profitability and Cash Flows in Q3, Raises 2024 Guidance Across the Board
-
Empowering Futures: HACE Launches $100,000 Fundraising Campaign to Support Current and Future Students and Leaders
-
War likely to wipe 9% off Lebanon's GDP, with fallout set to exceed 2006 conflict
-
Triple-I Campaign Raises Awareness of Legal System Abuse Impacts in Georgia
-
Boeing reports wider third-quarter loss as crucial union vote looms
-
HSBC CEO tells staff senior redundancies inevitable after revamp
-
Analysis-Sibanye's Montana woes underscore miners' growing reliance on Washington
-
Aspocomp’s Interim Report January-September 2024: Net sales and operating result decreased in the third quarter, orders received, and order book turned to strong growth
-
Natuzzi Shareholder Letter and Financial Results 2024 – Second Quarter and First Half Results
-
CN Announces Third Quarter Results
-
BioSig Technologies’ Common Stock to Resume Trading on the NASDAQ Exchange, Wednesday, October 23, 2024 After Its Successful Appeal to the NASDAQ Panel
-
Vidalia Companies, Inc. Announces Workforce Reduction Amid Strategic Growth Plan for Increased Pima Yarn Production
-
Oncternal Therapeutics Inc. (ONCT) Reports Updated Safety and Efficacy Data for Phase 1/2 Study of ONCT-534
-
Oncternal Therapeutics Announces Updated Safety and Efficacy Data for Phase 1/2 Study of ONCT-534 for the Treatment of R/R Metastatic Castration-Resistant Prostate Cancer
-
Clearside Biomedical's (CLSD) Positive ODYSSEY Wet AMD Data and Suprachoroidal Injection Platform Highlighted in Presentations at Multiple Events During AAO 2024 Annual Meeting
-
Clearside Biomedical’s Positive ODYSSEY Wet AMD Data and Suprachoroidal Injection Platform Highlighted in Presentations at Multiple Events During AAO 2024 Annual Meeting
-
3M raises annual profit forecast, explores sale of small businesses
-
Northvolt making progress towards securing financing package
-
Boeing exploring potential asset sales - WSJ
-
Cibus (CBUS) Announces Realigned Organization to Advance its Commercial Opportunities
-
Cibus Inc. Announces Realigned Organization to Advance its Commercial Opportunities
-
Norwegian bank DNB to buy Sweden's Carnegie for $1.14 billion
-
Commercial Credit Group Inc. Celebrates 20 Years of Equipment Financing
-
Sanofi reaches deal on terms of sale of consumer health arm, say French government sources
-
European space chief says Europe must be able to compete globally
-
Activist Jana builds Lamb Weston stake, pushes for possible sale
-
FLAGSTAR BANK IMPLEMENTS WORKFORCE CHANGES AS PART OF ITS CONTINUED TRANSFORMATION AND COST REDUCTION STRATEGY
-
US weekly jobless claims unexpectedly fall
-
Bernstein analysts cut price target for Boeing, citing impact of ongoing strike
-
PPG to lay off 1,800 employees in cost-cut drive, sell coatings unit
-
SAGE Therapeutics (SAGE) Announces Strategic Reorganization to Prioritize ZURZUVAE Commercialization and Focus its Development Portfolio
-
Sage Therapeutics Announces Strategic Reorganization to Prioritize ZURZUVAE® Commercialization and Focus its Development Portfolio
-
Meta lays off employees at WhatsApp and Instagram, the Verge reports
-
Airbus says assessing financial impact of job cuts
-
EY survey reveals upcoming US presidential election will have notable impact on technology sector
-
ARC Awards $2 Million to the Jewish Healthcare Foundation to Build, Train, and Support Frontline Workforce in Nursing Homes in Pennsylvania
-
Cidara Therapeutics Announces Two Presentations on Drug-Fc Conjugate, CD388, at IDWeek 2024
-
Airbus to cut up to 2,500 jobs in defence and space
-
Exclusive-Ryanair to cut traffic estimate for next year due to plane delivery delays
-
Analysis-Chinese finance professionals switch careers as industry crackdown dims prospects
-
Paramount assures bonus payouts for co-CEOs even if they exit roles

